FOURKITES
FourKites today announces new additions to its senior leadership team to maximise customer value. Technology industry veteran Sean Fallon returns to FourKites as Chief Strategy Officer to drive strategy and support continued growth. Chief Product Officer Priya Rajagopalan takes on an expanded role that closely aligns customer operations and product development teams to maximise customer value. In addition, Mike DeAngelis (based in Denmark) joins as Head of International Solutions with a focus on ocean, having formerly worked at Maersk, WiseTech Global and project44.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231116700075/en/
FourKites appoints new executives to accelerate customer-driven innovation (Graphic: Business Wire)
FourKites’ 1,200 customers represent some of the largest and most complex supply chains in the world, and the platform touches over 50% of the Fortune 500. As global supply chains continue to grow in complexity, customers’ need for visibility beyond transportation has accelerated, and now requires end-to-end solutions that provide visibility into inventory, yards, warehouses, stores and beyond.
Gartner reflected this challenge in its 2023 Critical Capabilities for Real-Time Transportation Visibility Platforms report, and recognised FourKites as the top-scoring solution for the world’s most complex supply chains, specifically calling out the company’s “modal coverage and extended capabilities.” In addition, FourKites continues to garner accolades for its industry-leading innovation, most recently in FreightWaves’ FreightTech 25, which recognises the most innovative and disruptive companies in the freight technology sector. FourKites is the only visibility provider named to this year’s list — and together with Amazon Freight and J.B. Hunt, it is one of only three companies to appear on every list since 2018.
To support FourKites’ aggressive innovation agenda to provide maximum visibility for its customers, FourKites has expanded the scope of Chief Product Officer Priya Rajagopalan’s role to encompass customer operations, product and R&D. A seasoned business leader with over two decades of experience in product management, marketing and strategy, Rajagopalan has led FourKites’ Product team since 2016. She helped to build FourKites’ culture of customer-driven innovation, as many of FourKites’ platform capabilities have been developed in close collaboration with customers such as Land O’Lakes, Coca-Cola, Kimberly-Clark, Walmart Canada and others.
In addition, FourKites announced the return of Sean Fallon as Chief Strategy Officer to manage operational execution. Fallon is a seasoned technology executive and advisor, with extensive experience in private equity and venture-backed companies. With a focus on advancing enterprise software and SaaS businesses, he has led businesses through strategic liquidity events and M&A, including the sale of BigMachines to Oracle in 2013. Fallon served as President at FourKites from 2017 to 2021.
FourKites has also appointed Mike DeAngelis as Head of Ocean, where he will drive strategy and innovation around FourKites’ ocean solutions. A proven industry leader, DeAngelis served as General Manager and Head of Product Management at Maersk, Senior VP of global carrier strategy at WiseTech Global, and was most recently Senior Director of Growth, Ocean, at project44.
“We are excited to announce these appointments at a time when customers are looking for more opportunities for digitisation than ever before,” said Mathew Elenjickal, FourKites founder and CEO. “These additions bring a tight connection between the voice of the customer and our high-velocity R&D team, which will yield accelerated opportunities for innovation and customer value.”
These appointments come at a time of continued company growth as customers increasingly seek solutions beyond transportation visibility. Over the last year, FourKites has achieved a 28% increase in customers; 37% growth in its carrier network; and nearly 30% growth in shipment volume, across more than 220 countries and territories. The company sets the pace of innovation in the supply chain visibility market — most recently with Inbound Visibility, Appointment Manager, Fin AI (FourKites Intelligence Network) and My Workspace — as FourKites continues to expand its capabilities beyond transportation to provide customers with real-time insights that expedite decision-making throughout their end-to-end supply chain operations.
About FourKites
Leading global supply chain visibility platform FourKites® empowers business leaders with comprehensive visibility into transportation, yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231116700075/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press release
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancerFDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currentl
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
